| Acute Phase Response Signaling |
2.85E+01 |
3.00E-01 |
1.177 |
| LXR/RXR Activation |
2.42E+01 |
3.20E-01 |
−1.718 |
| Coagulation System |
2.28E+01 |
6.57E-01 |
−0.209 |
| Intrinsic Prothrombin Activation Pathway |
2.23E+01 |
7.24E-01 |
0.229 |
| Complement System |
2.20E+01 |
6.22E-01 |
−0.5 |
| FXR/RXR Activation |
1.92E+01 |
2.72E-01 |
NaN |
| Protein Ubiquitination Pathway |
1.31E+01 |
1.63E-01 |
NaN |
| Extrinsic Prothrombin Activation Pathway |
1.23E+01 |
6.67E-01 |
NaN |
| Autophagy |
6.27E+00 |
2.32E-01 |
NaN |
| NRF2-mediated Oxidative Stress Response |
5.64E+00 |
1.26E-01 |
3.742 |
| Phagosome maturation |
5.58E+00 |
1.42E-01 |
NaN |
| Clathrin-mediated Endocytosis Signaling |
5.29E+00 |
1.21E-01 |
NaN |
| IL-12 Signaling and Production in Macrophages |
5.25E+00 |
1.35E-01 |
NaN |
| IGF-1 Signaling |
4.83E+00 |
1.48E-01 |
NaN |
| Inhibition of Matrix Metalloproteases |
4.50E+00 |
2.31E-01 |
NaN |
| Production of Nitric Oxide and ROS in Macrophages |
4.34E+00 |
1.11E-01 |
−1.279 |
| HIPPO signaling |
4.13E+00 |
1.51E-01 |
−3.464 |
| Agranulocyte Adhesion and Diapedesis |
3.67E+00 |
1.08E-01 |
NaN |
| RhoGDI Signaling |
3.61E+00 |
1.07E-01 |
0.943 |
| Hypoxia Signaling in the Cardiovascular System |
3.48E+00 |
1.59E-01 |
NaN |
| Unfolded protein response |
3.41E+00 |
1.70E-01 |
NaN |
| Myc Mediated Apoptosis Signaling |
3.11E+00 |
1.43E-01 |
NaN |
| Antigen Presentation Pathway |
3.06E+00 |
1.89E-01 |
NaN |
| Granulocyte Adhesion and Diapedesis |
3.05E+00 |
1.02E-01 |
NaN |
| Cell Cycle: G2/M DNA Damage Checkpoint Regulation |
2.97E+00 |
1.63E-01 |
1.342 |
| PI3K/AKT Signaling |
2.95E+00 |
1.10E-01 |
1.604 |
| Actin Cytoskeleton Signaling |
2.73E+00 |
8.85E-02 |
0.728 |
| Remodeling of Epithelial Adherens Junctions |
2.70E+00 |
1.36E-01 |
2 |
| p70S6K Signaling |
2.66E+00 |
1.03E-01 |
−1.89 |
| Regulation of Cellular Mechanics by Calpain Protease |
2.59E+00 |
1.43E-01 |
1 |
| Axonal Guidance Signaling |
2.46E+00 |
7.16E-02 |
NaN |
| ILK Signaling |
2.36E+00 |
8.76E-02 |
0 |
| Leukocyte Extravasation Signaling |
2.35E+00 |
8.53E-02 |
0.258 |
| ERK5 Signaling |
2.23E+00 |
1.25E-01 |
NaN |
| VDR/RXR Activation |
2.21E+00 |
1.15E-01 |
NaN |
| 14-3-3-mediated Signaling |
1.96E+00 |
9.16E-02 |
2.646 |
| Endoplasmic Reticulum Stress Pathway |
1.95E+00 |
1.90E-01 |
NaN |
| Wnt/Beta-catenin Signaling |
1.88E+00 |
8.38E-02 |
−0.707 |
| Antioxidant Action of Vitamin C |
1.83E+00 |
9.52E-02 |
0.378 |
| Role of Tissue Factor in Cancer |
1.82E+00 |
9.09E-02 |
NaN |
| RhoA Signaling |
1.79E+00 |
9.02E-02 |
1 |
| Mitotic Roles of Polo-Like Kinase |
1.74E+00 |
1.11E-01 |
NaN |
| Lipid Antigen Presentation by CD1 |
1.74E+00 |
1.67E-01 |
NaN |
| Tumoricidal Function of Hepatic Natural Killer Cells |
1.74E+00 |
1.67E-01 |
NaN |
| Aldosterone Signaling in Epithelial Cells |
1.72E+00 |
8.00E-02 |
NaN |
| LPS/IL-1 Mediated Inhibition of RXR Function |
1.66E+00 |
7.51E-02 |
−0.816 |
| Epithelial Adherens Junction Signaling |
1.64E+00 |
8.28E-02 |
NaN |
| Semaphorin Signaling in Neurons |
1.63E+00 |
1.15E-01 |
NaN |
| Dendritic Cell Maturation |
1.57E+00 |
7.65E-02 |
1.069 |
